← brief for 2026-09-16 · Slowing decline

The Incretin Revolution: Integrating Incretin-Based Therapies into Clinical Care.

Key takeaways

This narrative review summarizes how GLP-1 drugs and tirzepatide help not just blood sugar but also the heart, kidneys, liver, and breathing — and notes that some now have official approval for organ protection. No new trial data is presented.

Who did this work

Wojeck BS · Nokes B

Source

Article · PubMed, the drug frontier · 2026 Sep 14
https://pubmed.ncbi.nlm.nih.gov/42735880/